A Phase III Randomized Double Blind Placebo Controlled Multicenter Study to Assess the Efficacy Safety and Tolerability of Prochieve 8% Progesterone Gel in Preventing Preterm Delivery in Pregnant Women at Increased Risk for Preterm Delivery

Grants and Contracts Details

StatusFinished
Effective start/end date3/1/042/28/07

Funding

  • Quintiles Inc: $22,390.00